Mainstream

Biomarin raises 2025 full year guidance with $3.125b revenue target and advances bmn 333

BioMarin raises 2025 full-year guidance with $3.125B revenue target and advances BMN 333

BioMarin raises 2025 full-year guidance with $3.125B revenue target and advances BMN 333

Post ContentbmrnRead More

You might also be interested in reading MetaMask brings 200+ tokenized U.S. stocks and ETFs to users via Ondo.

August 5, 2025
In Mainstream